Nathan Vidal
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Methylphenidate and manic relapse in bipolar disorders: A replication study in a nationwide claims database.
Journal: Journal of psychopharmacology (Oxford, England)
Published: May 14, 2026
Nationwide trends in psychiatric prescription practices for drugs with putative cognitive adverse effects in schizophrenia spectrum and bipolar disorders from 2013 to 2022.
Journal: Journal of pharmaceutical policy and practice
Published: April 03, 2026
Examining the associations between manic symptoms and cognitive performance in bipolar disorders: evidence from a cross-sectional replication study in the FACE-BD cohort.
Journal: International journal of bipolar disorders
Published: September 24, 2025
Neural network analysis of the contribution of psychotropic prescription sequences to the risk of non-psychiatric adverse events in bipolar and schizophrenia spectrum disorders.
Journal: Frontiers in digital health
Published: May 22, 2025
Flowers for Algernon: How metacognition affects quality of life in schizophrenia. Structural equation modeling with the FACE-SZ cohort.
Journal: Comprehensive psychiatry
Published: March 05, 2025
Anticholinergic burden as a precipitating factor for delirium spectrum disorders in schizophrenia spectrum and bipolar disorders: A case-crossover study based on the French nationwide claims database.
Journal: Journal of psychiatric research
Published: February 05, 2025
Relationships between cognition, functioning, and quality of life of euthymic patients with bipolar disorder: Structural equation modeling with the FACE-BD cohort.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: November 15, 2024
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.
Journal: Frontiers in pharmacology
Published: March 18, 2024
Exploring the Association Between Residual Mood Symptoms and Self-Reported Side Effects in the Euthymic Phase of Bipolar Disorders: A Cross-Sectional Network Analysis.
Journal: Depression and anxiety
Published: February 02, 2024
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: April 11, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026